Development of Highly Sensitive Biosensors of RAF Dimerization in Cells.
Ontology highlight
ABSTRACT: The BRAF inhibitors dabrafenib and vemurafenib induce remarkable clinical responses in patients with BRAF-mutated melanomas. However, adverse events, including the emergence of secondary tumors and drug resistance, have been reported. Studies have revealed that undesirable RAF dimerization induced by inhibitors promotes these adverse effects. Here, we developed highly sensitive biosensors of RAF dimerization in cells utilizing the split enhanced click beetle luciferase (Emerald Luc, ELuc) complementation technique. We demonstrated that our biosensor system works effectively for high-throughput screens in the microplate format. A comprehensive analysis of commercially available RAF inhibitors performed using this assay system revealed that the inhibitors exhibit various potencies in inducin
SUBMITTER: Miyamoto K
PROVIDER: S-EPMC6345758 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA